UNITED THERAPEUTICS Corp 4

Ray Kurzweil, a non-employee director of United Therapeutics Corp (UTHR), received 380 restricted stock units and stock options for 1,190 shares as part of his annual director equity award.

On July 22, 2026, United Therapeutics Corp non-employee director Ray Kurzweil received an annual equity compensation package consisting of 380 restricted stock units and options to purchase 1,190 shares of common stock, both granted at no cost as director awards. The RSUs each represent the right to receive one share of common stock upon vesting and are expected to fully vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of shareholders, anticipated on June 25, 2027; the options have an exercise price of $527.07 per share and an expiration date of July 22, 2033. Following these awards, Kurzweil directly holds 13,320 shares of common stock, excluding the newly granted but unvested RSUs and unexercised options, indicating a routine, compensation-related increase in his equity-based incentives rather than an open-market purchase or sale.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001108501-26-000003

Alert Tier

5